Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132916) titled 'Machine learning-based prediction of retroperitoneal tumor subtypes, grading, and prognosis using multi-modal data' on Sept. 20.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: ShangHai ChangHai Hospital
Condition:
Retroperitoneal neoplasm
Intervention:
Gold Standard:Pathological results
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-04-01
Target Sample Size: Target condition:1200;Difficult condition:300
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343473
Published by HT Digital...